Can you tell me how you have arrived at the $5B cash by next year as I'm not anywhere close to that.
My numbers suggest by mid next year the company will have closer to $2-2.4B in cash as they still have a large tax bill to pay, they have large capex spend underway and the Spodumene price has dropped substantially.
I also have a forecast PE ratio of around 11.5 for 2023/34 compared to your 4.7 and the average forecast from the 12 brokers on morning star is a PE of 12.9 for 2023/24 and 12.6 for 2024/45
I do agree though that the company still has a strong balance sheet and is fair value at current prices.
Good News & Bad News, page-36173
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.24 |
Change
-0.080(2.41%) |
Mkt cap ! $9.751B | |||
| Open | High | Low | Value | Volume |
| $3.26 | $3.32 | $3.23 | $83.81M | 25.68M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 106287 | $3.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.25 | 157742 | 3 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$3.24 |
Change
-0.080 ( 2.40 %) |
||||
| Open | High | Low | Volume | ||
| $3.27 | $3.32 | $3.23 | 21533662 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| PLS (ASX) Chart |